EUVIMEDEUVIMED entdecken
Open Access

Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data

Jessica Yu, Sachie Mochida, Michele Emery, Patrick Carroll, Justin Ko, Arash Mostaghimi

JMIR Dermatology · 2026

DOI: 10.2196/84676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Dermatology, 2026. Verfasst von Jessica Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hims & Hers Health, Inc, 2269 Chestnut Street, Suite 523, San Francisco, CA, 94123, United States, 1 6508048434. Hauptthemen laut MEDLINE: Patient Satisfaction, Finasteride, Alopecia, 5-alpha Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Topical minoxidil and oral finasteride are approved by the US Food and Drug Administration (FDA) for the treatment of male androgenetic alopecia (AGA). However, concerns about adverse events related to the use of oral finasteride have led to some apprehension about the treatment. Topical finasteride, though not FDA-approved, has demonstrated efficacy and safety in a limited number of clinical trials and may be a promising alternative, such that compounding pharmacies and telehealth companies in the United States now offer access to topical finasteride for patients with AGA.

Objective

This real-world, retrospective study is, to our knowledge, the largest study to date aimed to evaluate patient satisfaction and tolerability associated with the novel combinations of topical finasteride and topical minoxidil for the treatment of male AGA.

Methods

We conducted a retrospective analysis of patient data collected during routine clinical follow-up via Hims & Hers, a direct-to-consumer health and wellness platform, between April 1, 2021 and April 30, 2025 to assess the frequency of side effects and other possible medication reactions associated with the use of compounded topical finasteride and minoxidil. Data were gathered from two sources: (1) a follow-up check-in sent to patients approximately 130 days following the initiation of treatment; (2) unprompted communications sent via in-app or web-based messaging from patients to their care team. Data about patient satisfaction with treatment, the frequency of any side effect, frequency of specific side effects, need for a higher level of care, and treatment discontinuation due to a side effect were extracted from the data sources.

Results

A total of 638,629 male patients with AGA received a prescription for a compounded topical finasteride and minoxidil product between April 1, 2021 and April 30, 2025. Of 151,352 (23.7%) patients who completed a follow-up check-in, 121,615 (80.4%) reported being satisfied with treatment and 4034 (2.7%) reported experiencing a side effect. Of all the 638,629 patients, 230 (0.04%) sent their care team a message (outside of check-ins) indicating a side effect or other possible medication reactions. No patient reported seeking a higher level of care or discontinued treatment due to such an occurrence.

Conclusions

Patients prescribed novel formulations of compounded topical finasteride and minoxidil for the treatment of AGA via a national telehealth platform reported satisfaction with the treatment and tolerated it well. The limitations of the study include the use of retrospective data and the lack of a control group, both of which preclude causal inference. Future research should include randomized controlled trials to assess the efficacy, safety, and tolerability of topical finasteride.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SatisfactionFinasterideAlopecia5-alpha Reductase InhibitorsHumansMaleRetrospective StudiesAdultMiddle AgedMinoxidilTelemedicineAdministration, TopicalUnited StatesDrug Compounding

Stichwörter der Autor:innen

androgenetic alopeciapatient satisfactionside effectstelehealthtopical finasteridetopical minoxidil

Substanzen

FinasterideMinoxidil5-alpha Reductase Inhibitors

Autor:innen und Institutionen

  • Hims & Hers Health, Inc, 2269 Chestnut Street, Suite 523, San Francisco, CA, 94123, United States, 1 6508048434.
  • Department of Dermatology, Stanford University School of Medicine, Stanford, CA, United States.
  • Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States.

Zitieren

APA

Yu, J., Mochida, S., Emery, M., Carroll, P., Ko, J., & Mostaghimi, A. (2026). Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data. JMIR Dermatology. https://doi.org/10.2196/84676

Vancouver

Yu J, Mochida S, Emery M, Carroll P, Ko J, Mostaghimi A. Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data. JMIR Dermatology. 2026. doi:10.2196/84676

BibTeX
@article{Yu2026,
  author = {Yu, Jessica and Mochida, Sachie and Emery, Michele and Carroll, Patrick and Ko, Justin and Mostaghimi, Arash},
  title = {Patient Satisfaction, Side Effects, and Other Reactions Reported by Adult Men Prescribed Compounded Topical Finasteride via a National Telehealth Platform: Retrospective Analysis of Real-World Data},
  journal = {JMIR Dermatology},
  year = {2026},
  doi = {10.2196/84676}
}
Kostenlos starten →